Injection innovation for safety, equity, and access – at a disruptive price.

 About Us



• • • • • • • • • • • • • •

Marc Koska, OBE

The inventor of ApiJect, the first BFS injection device, is Marc Koska, one of the world’s most respected and successful social entrepreneurs.

In the mid-1980’s, Mr. Koska invented the K-1 Auto-Disposable-Syringe, a device that stops the spread of blood borne diseases and infection by making it impossible to reuse medical needles and syringes. In 2005, he founded the nonprofit SafePoint Trust to educate children about the dangers of employing used needles.

To date, Marc’s invention and leadership are estimated to have saved 10 million lives. In 2015, WHO director, Dr. Margaret Chan announced a new global policy on injection safety, promoting auto-disable-syringes. The K-1 is now licensed and manufactured by 14 global manufacturers. Among many other honors bestowed on Mr. Koska, he was made an Officer of the Order of the British Empire for his “contribution to global healthcare”.



Jay Walker

Jay Walker leads ApiJect’s technology efforts, as well as its business and commercialization activities. He is best known as the founder of Priceline and curator of TEDMED.

A serial entrepreneur, Mr. Walker has founded three companies that have gone from launch to 50 million customers each. Mr. Walker is the world’s 10th most patented inventor, with more than 750 issued U.S. patents in technology-related fields.

Active in the field of medicine since 2012, Mr. Walker serves as chairman and curator of TEDMED, the health and medicine edition of the world-famous TED Conference. He is also Chairman of Upside, a travel and technology company that serves the unmanaged business traveler. A passionate student and practitioner of imagination, Mr. Walker founded and curated the Library of the History of Human Imagination, which Wired Magazine called, “the most amazing private library in the world.”




• • • • • • • • • • • • • •

Tae-Chang Industries

CEO: Hanjin In

South Korea: Tae-Chang Industrial Co., Ltd. of South Korea is a global manufacturer of needle products, all of which are GMP, ISO and CE certified. Established more than 25 years ago T-C Industrial exports to more than 50 nations including the U.S. and Japan.

The Company’s product development team and facilities supply global clients while serving as an OEM supplier to all major medical suppliers in the region.

T-C Industrial’s next plant – its 6th – will be a 150,000 sq. ft. facility dedicated to ApiJect production.


HMD Healthcare

CEO: Rajiv Nath

ApiJect will design its products specifically for the Indian, South Asian and Southeast Asian markets in cooperation with HMD Healthcare (Hindustan Medical Devices), one of the world’s five largest syringe suppliers.

HMD has been manufacturing and supplying medical disposables for more than 60 years. Some 3,500 HMD employees at plants across South Asia supply more than 60% of India’s disposable syringes, while producing more than 3.5 billion needles.

The Joint Managing Director of HMD is Rajiv Nath. He also serves as the President of the All India Syringes & Needles Mfg. Assn. and is the Founder and Forum Coordinator for the Assn. of Indian Medical Device Industry (AiMeD).

Rommelag BFS facility.jpg


CEO: Bernd Hansen

Rommelag is the inventor of BFS technology and the world’s leading manufacturer of BFS machines. Its 1,800+ employees serve customers in more than 80 countries around the world. It currently delivers vaccines and medicine in BFS packaging.

Rommelag is committed to provide contract BFS fill support and BFS machine sales to manufacturers. The company’s contract manufacturing subsidiary has invested $50 million to build a new BSL-2 filling plant in Zell, Switzerland. The Zell facility is in full operation currently and will support ApiJect.

Bernd Hansen’s father Gerhard Hansen was the inventor of the Blow-Fill-Seal technology and founder of Rommelag in 1964. After studying electrical engineering, Bernd joined Rommelag in 1981 and became its CEO in 1985.



CEO: Jahja Tear Tjahjana

OneJect Indonesia employs more than 300 employees in its 53,800 sq. ft. facility, housing manufacturing, engineering and R&D for medical devices.

Established in 2004, OneJect is Indonesia’s exclusive licensee for Marc Koska’s K1 Auto-Disable syringe. Though not currently a UNICEF supplier, OneJect is Indonesia’s largest distributor for government vaccine and family planning programs and is supported by Gavi.

Chairman Jahja Tear Tjahjana founded OneJect’s original parent company, a general services contractor, in 1990. By 1994 he had expanded the company into large-scale infrastructure construction (public housing, airport facilities, etc.). OneJect is among a dozen companies that Mr. Tjahjana has launched or acquired since 1990.


FMW Group

Partners: Tobias Wilke, Bernd Mohr, Stephan Fischer

FMW is a developer of fine plastic products and a creator of the highest standard molds, which includes prototype, pre-production and serial production molds. They serve customers across the globe and in a variety of industries, including Medical Devices, Automotive, Packaging & Baby Products.

The FMW Group’s three partners (Bernd Mohr, Stephan Fischer, Tobias Wilke) have each spent more than 20 years as senior executives or owners of larger globally active companies in the plastics (injection molding) and the toolmaking industries.

FMW is the inventor of various “safety caps” for standard syringes, including the “F Series”. These are distributed by a partner worldwide under license.